Table 5 Sensitivity analyses
PWP model | PNP model | Purely public model | ||||
|---|---|---|---|---|---|---|
Site 1 | Site 2 | Site 3 | Site 4 | Site 5 | Site6 | |
Alternative estimates of provider costs (staff time) | ||||||
• % divergence from base-case provider cost estimate | -15% | -13% | -8% | -8% | -24% | -28% |
• % divergence from base-case provider cost-effectiveness estimate | -15% | -13% | -8% | -8% | -24% | -28% |
Lower limit patient cost | ||||||
• % divergence from base-case patient cost estimate | N.A.* | N.A. | -5% | -5% | -5% | -5% |
• % divergence from base-case patient cost-effectiveness estimate | N.A. | N.A. | -4% | -3% | -1% | -1% |
Upper limit patient cost | ||||||
• % divergence from base-case patient cost estimate | N.A. | N.A. | +5% | +5% | +5% | +5% |
• % divergence from base-case patient cost-effectiveness estimate | N.A. | N.A | +3% | +0.2% | +0.6% | +2% |
0% discount rate | ||||||
• % divergence from base-case provider cost estimate | -3% | -3% | -3% | -3% | -3% | -3% |
• % divergence from provider cost-effectiveness estimate | -2% | -0.6% | -0.5% | -2% | -1% | -0.5% |
6% discount rate | ||||||
• % divergence from base-case provider cost estimate | +3% | +3% | +3% | +3% | +3% | +3% |
• % divergence from provider cost-effectiveness estimate | +3% | +2% | +2% | +3% | +2% | +2% |
Effectiveness adjusted by the death rate** | ||||||
• % divergence from base-case treatment success rate | -12% | -11% | -4% | -8% | -1% | -2% |
• % divergence from base-case societal cost-effectiveness estimate (treatment success rate) | -12% | -11% | -4% | -8% | -1.6% | -2.5% |
• % divergence from base-case cure rate | -12% | -11% | -4% | -8% | -1% | -2% |
• % divergence from base-case societal cost-effectiveness estimate (cure rate) | -12% | -11% | -4% | -8% | -1% | -2% |
Multivariate analysis (estimates of provider cost and effectiveness adjusted by the death rate are varied at the same time) | ||||||
• % divergence from base-case provider cost estimate | -15% | -13% | -8% | -8% | -24% | -28% |
• % divergence from base-case cure rate | -12% | -11% | -4% | -8% | -1% | -2% |
• % divergence from base-case societal cost-effectiveness estimate | -25% | -23% | -11% | -15% | -25% | -30% |